Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam B Weinglass

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Molecular Pharmacology|August 30, 2008
ProTx-II, a selective inhibitor of NaV1.7 sodium channels, blocks action potential propagation in nociceptorsWilliam A Schmalhofer, Jeffrey Calhoun, Rachel Burrows, et al.
Biochemistry|August 16, 2006
Characterization of Kir1.1 channels with the use of a radiolabeled derivative of tertiapinJohn P Felix, Jessica Liu, William A Schmalhofer, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
A non-canonical mechanism of GPCR activationAlexander S Powers, Aasma Khan, Joseph M Paggi, et al.
Nature Communications|November 16, 2024
A non-canonical mechanism of GPCR activationAlexander S Powers, Aasma Khan, Joseph M Paggi, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 7, 2008
Extracellular loop C of NPC1L1 is important for binding to ezetimibeAdam B Weinglass, Martin Kohler, Uwe Schulte, et al.
American Journal of Physiology. Endocrinology and Metabolism|March 16, 2017
GPR40 reduces food intake and body weight through GLP-1Judith N Gorski, Michele J Pachanski, Joel Mane, et al.
Molecular Metabolism|February 17, 2015
GPR40 (FFAR1) - Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivoMaria Hauge, Marie A Vestmar, Anna S Husted, et al.
Molecular Pharmacology|January 12, 2008
Madin-Darby canine kidney II cells: a pharmacologically validated system for NPC1L1-mediated cholesterol uptakeAdam B Weinglass, Martin G Köhler, Emmanuel O Nketiah, et al.
Plos One|May 26, 2017
GPR40 partial agonist MK-2305 lower fasting glucose in the Goto Kakizaki rat via suppression of endogenous glucose productionCorin Miller, Michele J Pachanski, Melissa E Kirkland, et al.
Plos One|October 21, 2017
GPR40 partial agonists and AgoPAMs: Differentiating effects on glucose and hormonal secretions in the rodentMichele J Pachanski, Melissa E Kirkland, Daniel T Kosinski, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Molecular Pharmacology|August 30, 2008
ProTx-II, a selective inhibitor of NaV1.7 sodium channels, blocks action potential propagation in nociceptorsWilliam A Schmalhofer, Jeffrey Calhoun, Rachel Burrows, et al.
Biochemistry|August 16, 2006
Characterization of Kir1.1 channels with the use of a radiolabeled derivative of tertiapinJohn P Felix, Jessica Liu, William A Schmalhofer, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
A non-canonical mechanism of GPCR activationAlexander S Powers, Aasma Khan, Joseph M Paggi, et al.
Nature Communications|November 16, 2024
A non-canonical mechanism of GPCR activationAlexander S Powers, Aasma Khan, Joseph M Paggi, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 7, 2008
Extracellular loop C of NPC1L1 is important for binding to ezetimibeAdam B Weinglass, Martin Kohler, Uwe Schulte, et al.
American Journal of Physiology. Endocrinology and Metabolism|March 16, 2017
GPR40 reduces food intake and body weight through GLP-1Judith N Gorski, Michele J Pachanski, Joel Mane, et al.
Molecular Metabolism|February 17, 2015
GPR40 (FFAR1) - Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivoMaria Hauge, Marie A Vestmar, Anna S Husted, et al.
Molecular Pharmacology|January 12, 2008
Madin-Darby canine kidney II cells: a pharmacologically validated system for NPC1L1-mediated cholesterol uptakeAdam B Weinglass, Martin G Köhler, Emmanuel O Nketiah, et al.
Plos One|May 26, 2017
GPR40 partial agonist MK-2305 lower fasting glucose in the Goto Kakizaki rat via suppression of endogenous glucose productionCorin Miller, Michele J Pachanski, Melissa E Kirkland, et al.
Plos One|October 21, 2017
GPR40 partial agonists and AgoPAMs: Differentiating effects on glucose and hormonal secretions in the rodentMichele J Pachanski, Melissa E Kirkland, Daniel T Kosinski, et al.
Pageof 3